wyszukanych pozycji: 3
Preserving the Promise: Improving the Culture of Biotech Investment
ISBN: 9780128092163 / Angielski / Miękka / 2016 / 276 str. Termin realizacji zamówienia: ok. 18-20 dni roboczych. Preserving the Promise: Improving the Culture of Biotech Investment critically examines why most biotech startups fail, as they emerge from universities into an ecosystem that inhibits rather than encourages innovation. This "Valley of Death" squanders our public investments in medical research and with them, the promise of longer and healthier lives. The authors explicate the Translation Gap faced by early stage biotech companies, the result of problematic technology transfer and investment practices, and provide specific prescriptions for improving translation of... Preserving the Promise: Improving the Culture of Biotech Investment critically examines why most biotech startups fail, as they emerge from ... |
|
cena:
188,92 zł |
Human Antibody Therapeutics for Viral Disease
ISBN: 9783540721444 / Angielski / Twarda / 2007 / 188 str. Termin realizacji zamówienia: ok. 20 dni roboczych. Although the utility of human antibodies as medical therapeutics for cancer and immune diseases has been well-established, it is only beginning to be realized for the treatment of viral infectious diseases. Polyclonal immunoglobulins have long been used for some viral diseases, but they have limited potency and disease scope. It should theoretically be possible to create monoclonal or oligoclonal antibody preparations that capture the essential curative functions of the humoral immune response to viral pathogens, yet only a single humanized monoclonal antibody (pavilizumab) has been... Although the utility of human antibodies as medical therapeutics for cancer and immune diseases has been well-established, it is only beginning to ... |
|
cena:
580,98 zł |
Human Antibody Therapeutics for Viral Disease
ISBN: 9783642091315 / Angielski / Miękka / 2010 / 190 str. Termin realizacji zamówienia: ok. 20 dni roboczych. Although the utility of human antibodies as medical therapeutics for cancer and immune diseases has been well-established, it is only beginning to be realized for the treatment of viral infectious diseases. Polyclonal immunoglobulins have long been used for some viral diseases, but they have limited potency and disease scope. It should theoretically be possible to create monoclonal or oligoclonal antibody preparations that capture the essential curative functions of the humoral immune response to viral pathogens, yet only a single humanized monoclonal antibody (pavilizumab) has been... Although the utility of human antibodies as medical therapeutics for cancer and immune diseases has been well-established, it is only beginning to ... |
|
cena:
580,98 zł |